News and Events

Chengkai Dai appointed to Senior Investigator at CCR

The CCR community congratulates Chengkai Dai, Ph.D., who has been appointed Senior Investigator in the Mouse Cancer Genetics Program. Dai’s laboratory is a pioneer in the field of proteomic instability of cancer. His ongoing research focuses on the molecular mechanisms through which proteomic instability may affect genomic stability, cell invasion and autophagy, areas which hold promise to unveil new molecular pathways that could be targeted in cancer therapy.

Read More

Aligned Blog: Knowledge is Power: The Value and Importance of Genetic Counseling

This year's U.S. Food and Drug Administration's 4th Annual National Black Family Cancer Awareness Week falls from June 13-19, 2024. In honor of the theme, "Engaging Generations," we invited Michaela Taylor, M.S., CGC, Cancer Genetics Counselor in the Genetics Branch to write about the value of genetic counseling for Black and African American people and how broaching this sometimes difficult topic can lead to empowerment. 

Read More

NIH scientists develop AI tool to predict how cancer patients will respond to immunotherapy

In a proof-of-concept study, CCR researchers developed an artificial intelligence (AI) tool that uses routine clinical data to predict whether someone’s cancer will respond to immune checkpoint inhibitors. The machine-learning model may help doctors determine if these immunotherapy drugs are effective for treating a patient’s cancer. The study, published June 3, 2024, in Nature Cancer, was led by Eytan Ruppin, M.D., Ph.D., Chief of the Cancer Data Science Laboratory, and collaborators at Memorial Sloan Kettering Cancer Center in New York. 

Read More

Benign nail condition linked to rare syndrome that greatly increases cancer risk

Researchers from CCR and the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) discovered the presence of a benign nail abnormality may lead to the diagnosis of a rare inherited disorder that increases the risk of developing cancerous tumors. The study suggests conducting nail evaluation of affected patients and at-risk family members. 

Read More